Emerging Technologies

Sam Glassenberg, CEO and founder of Level Ex, discusses the company's immersive experiences and the prospects of the metaverse for healthcare training and delivery.

NeuTrace focused on developing in-procedure AI tools for electrophysiology.

The Wisconsin Department of Health Services plans to make reSET and reSET-O available through providers in outpatient settings.

Adam Elsesser, president, chairman and CEO of Penumbra, describes the medical device company's move into virtual reality and how its REAL system helps therapists measure a patient's progress.   

The multinational pharma company will now be able to access Tempus' de-identified patient data.

The company will use the funds to expand its platform and accelerate global commercialization.

The partnership will allow MyndVR to expand its content offerings for older adults.

The startup builds machine learning tools that aim to understand speech, feelings and nonverbal cues like sighs, laughs and gasps.

A review published in JAMA Network Open evaluated 41 RCTs of machine learning interventions. None of the studies fully followed CONSORT-AI standards, a set of guidelines developed for clinical trials evaluating medical interventions that include AI.

Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.